These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 21036614

  • 1. Stage migration and therapy modification after thoracoscopic internal mammary lymph node dissection in breast cancer patients.
    Long H, Lin Z, Situ D, Ma G, Zheng Y, Rong T.
    Breast; 2011 Apr; 20(2):129-33. PubMed ID: 21036614
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thoracoscopic approach in the treatment of breast cancer relapse in the internal mammary lymph node.
    Conrado-Abrão F, Das-Neves-Pereira JC, Fernandes A, Jatene FB.
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):328-30. PubMed ID: 20576656
    [Abstract] [Full Text] [Related]

  • 5. A pilot study on thoracoscopic internal mammary lymphatic chain dissection for breast cancer.
    He Q, Jiang J, Yang X, Fan L, Guo M, Zhang Y.
    Breast; 2008 Dec; 17(6):568-73. PubMed ID: 18835167
    [Abstract] [Full Text] [Related]

  • 6. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
    Spillane AJ, Brennan ME.
    Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R.
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [Abstract] [Full Text] [Related]

  • 8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [Abstract] [Full Text] [Related]

  • 9. Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence.
    Noushi F, Spillane AJ, Uren RF, Gebski V.
    Breast; 2011 Jun; 20(3):278-83. PubMed ID: 21310616
    [Abstract] [Full Text] [Related]

  • 10. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP.
    Cancer; 2010 Mar 01; 116(5):1243-51. PubMed ID: 20087958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
    Jpn J Clin Oncol; 2005 Mar 01; 35(3):126-33. PubMed ID: 15741302
    [Abstract] [Full Text] [Related]

  • 13. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
    Daveau C, Stevens D, Brain E, Berges O, Villette S, Moisson P, Gardner M, De la Lande B, Lasry S, Labib A, Le Scodan R.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):337-42. PubMed ID: 20171795
    [Abstract] [Full Text] [Related]

  • 14. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE, Hwang WT, Seyednejad F, Solin LJ.
    Cancer; 2003 Nov 15; 98(10):2144-51. PubMed ID: 14601083
    [Abstract] [Full Text] [Related]

  • 15. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.
    Arch Surg; 2010 Jun 15; 145(6):564-9. PubMed ID: 20566977
    [Abstract] [Full Text] [Related]

  • 16. Internal mammary sentinel node biopsy for breast cancer: is it practicable and relevant? (Review).
    Noguchi M.
    Oncol Rep; 2002 Jun 15; 9(3):461-8. PubMed ID: 11956610
    [Abstract] [Full Text] [Related]

  • 17. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.
    Ai Zheng; 2005 Mar 15; 24(3):327-31. PubMed ID: 15757535
    [Abstract] [Full Text] [Related]

  • 18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 Mar 15; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.